Clinical trials
Shoulder Pain trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
153 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 11 |
| 2022 | 30 |
| 2023 | 19 |
| 2024 | 19 |
| 2025 | 20 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
| Recruiting | 24 |
| Unknown status | 13 |
| Not yet recruiting | 4 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istanbul University - Cerrahpasa | 14 |
| Hacettepe University | 10 |
| Istanbul University | 7 |
| Ankara City Hospital Bilkent | 5 |
| Ankara Yildirim Beyazıt University | 4 |
| Cukurova University | 4 |
| Marmara University | 4 |
| Afyonkarahisar Health Sciences University | 3 |
| Gazi University | 3 |
| Istanbul Medeniyet University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shoulder Pain | 153 |
| Shoulder Impingement Syndrome | 26 |
| Rotator Cuff Injuries | 23 |
| Bursitis | 12 |
| Postoperative Pain | 10 |
| Pain | 9 |
| Hemiplegia | 8 |
| Stroke | 7 |
| Agnosia | 6 |
| Shoulder Injuries | 6 |
Trials
Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.
53 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.